- Home
- DGX vs EQR Comparison
DGX vs EQR Comparison
Compare DGX & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- EQR
- Stock Information
- Founded
- DGX 1967
- EQR 1993
- Country
- DGX United States
- EQR United States
- Employees
- DGX N/A
- EQR N/A
- Industry
- DGX Medical Specialities
- EQR Real Estate Investment Trusts
- Sector
- DGX Health Care
- EQR Real Estate
- Exchange
- DGX Nasdaq
- EQR Nasdaq
- Market Cap
- DGX 20.5B
- EQR 24.5B
- IPO Year
- DGX 1996
- EQR 1993
- Fundamental
- Price
- DGX $178.94
- EQR $59.01
- Analyst Decision
- DGX Buy
- EQR Buy
- Analyst Count
- DGX 15
- EQR 11
- Target Price
- DGX $194.07
- EQR $73.68
- AVG Volume (30 Days)
- DGX 1.1M
- EQR 2.7M
- Earning Date
- DGX 10-21-2025
- EQR 10-28-2025
- Dividend Yield
- DGX 1.79%
- EQR 4.69%
- EPS Growth
- DGX 14.49
- EQR 24.49
- EPS
- DGX 8.51
- EQR 3.03
- Revenue
- DGX $10,850,000,000.00
- EQR $3,078,827,000.00
- Revenue This Year
- DGX $11.17
- EQR $5.00
- Revenue Next Year
- DGX $3.48
- EQR $3.68
- P/E Ratio
- DGX $21.00
- EQR $19.47
- Revenue Growth
- DGX 13.74
- EQR 4.69
- 52 Week Low
- DGX $148.70
- EQR $58.38
- 52 Week High
- DGX $197.55
- EQR $78.32
- Technical
- Relative Strength Index (RSI)
- DGX 45.00
- EQR 33.04
- Support Level
- DGX $174.33
- EQR $58.51
- Resistance Level
- DGX $178.88
- EQR $60.70
- Average True Range (ATR)
- DGX 4.42
- EQR 1.29
- MACD
- DGX -0.94
- EQR -0.31
- Stochastic Oscillator
- DGX 19.85
- EQR 11.24
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.